Select Language:
Scientists have identified a genetic variation in animals living at extremely high altitudes that might help repair damage in the human nervous system. This discovery could eventually pave the way for new therapies targeting brain and spinal cord diseases like multiple sclerosis and cerebral palsy. The research was published in the scientific journal Neuron.
Animals such as yaks and Tibetan antelopes inhabit the Tibetan Plateau, one of the highest regions on Earth, sitting around 14,700 feet above sea level where oxygen levels are significantly lower than at sea level. Maintaining normal bodily functions in such oxygen-deprived conditions is challenging for most animals and humans, especially for vital organs like the brain. Yet, many creatures native to this environment appear healthy and function normally.
For years, scientists have wondered how these animals survive and perform under such extreme conditions. Through evolution over thousands of years, these species developed genetic adaptations that allow them to thrive in low-oxygen environments. Studying these natural genetic changes might hold keys to helping humans better protect their health under similar conditions.
Liang Zhang, affiliated with Songjiang Hospital and Shanghai Jiao Tong University School of Medicine, is one of the researchers involved. Zhang emphasizes that nature offers numerous hidden solutions to medical challenges. By analyzing the genes of animals adapted to high altitude, researchers hope to uncover new avenues for treating human diseases.
The research focused on the Retsat gene, which previous studies showed often exists in a unique form among high-altitude animals. Scientists suspected that this variation could protect the brain from oxygen deprivation.
To investigate, the team studied newborn mice exposed to low-oxygen conditions mimicking those above 13,000 feet. These mice were divided into two groups: one carrying the high-altitude version of Retsat and the other the standard form. After about a week, their cognitive performance, memory, and social behaviors were tested. Mice with the high-altitude gene performed significantly better across all measures. Brain analyses revealed that these mice had stronger protection around nerve fibers.
Nerve fibers in the brain and spinal cord are covered by myelin, a layer that insulates and speeds up electrical signals. Damage to myelin hampers nerve function, leading to serious neurological problems. In infants, oxygen deprivation during brain development can cause myelin damage, resulting in cerebral palsy. In adults, demyelination is a hallmark of multiple sclerosis (MS), an autoimmune disease where the immune system attacks this protective layer. MS symptoms include muscle weakness, vision impairment, and mobility issues.
Myelin damage is also linked to aging-related neurological issues such as small vessel disease and vascular dementia. Because of this, researchers are exploring ways to promote myelin repair.
The study revealed that mice with the high-altitude Retsat gene regenerated damaged myelin much more quickly than typical mice. Their brains showed more mature oligodendrocytes—cells responsible for producing and maintaining myelin. Further tests indicated that these mice produced higher levels of a molecule called ATDR, derived from vitamin A. This molecule increased due to enhanced activity of an enzyme stimulated by the Retsat variation.
When scientists administered ATDR to mice with a condition similar to MS, they observed reduced disease severity and improved mobility. Current MS treatments mainly aim to suppress the immune response, slowing myelin damage, but they don’t directly promote repair. The new findings suggest that boosting natural molecules like ATDR could present an alternative approach—stimulating the body’s capacity to rebuild lost nerve insulation.
While promising, these results are preliminary. The experiments were conducted in mice, and further research is essential to establish safety and effectiveness in humans. Clinical trials will be necessary before such treatments could become available.
Nevertheless, this study highlights how understanding natural biological mechanisms may lead to innovative therapies. Animals adapted to extreme environments might hold critical clues for helping humans protect and heal their nervous systems.
In summary, a genetic adaptation allowing animals to survive at high altitudes might also assist in repairing damaged nerves in humans. As scientists delve deeper into evolution—and the genes responsible for these adaptations—they could develop new treatments that improve life for those with neurological conditions involving myelin damage.
Future research may confirm if molecules involved in vitamin A metabolism can become vital tools in combatting diseases like multiple sclerosis and other demyelinating disorders.




